Xu Teng

机构：Hebei Medical University · ORCID：0000-0002-0566-5859

发表论文 51 篇 · 总被引 718 次 · h-index 16

代表论文

• The m6A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN (2024 · Molecular Cancer · 被引 75)
• TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling (2023 · Journal of Experimental & Clinical Cancer Research · 被引 43)
• Survival stratification for colorectal cancer via multi-omics integration using an autoencoder-based model (2021 · Experimental Biology and Medicine · 被引 28)
• Utility of a Simple Scoring System in Differentiating Bacterial Infections in Cases of Fever of Unknown Origin (2020 · Clinical Infectious Diseases · 被引 21)
• Development of a risk prediction model for bloodstream infection in patients with fever of unknown origin (2022 · Journal of Translational Medicine · 被引 17)
• Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway (2021 · Cell Communication and Signaling · 被引 17)